In a filing reported Tuesday, PAVS filed a prospectus supplement authorizing the sale of up to $194.9 million in Class A Ordinary Shares through AC Sunshine Securities LLC, which will earn a 3.5% commission on gross sales.Tuesday’s Wild Ride: From $1.55 to $26.69 and BackTuesday’s regular session was nothing short of extraordinary for PAVS shareholders. The stock opened at $1.55, rocketed to an intraday high of $26.69 — a surge of 1,621.94% — before suffering multiple trading halts and eventually collapsing to $1.02, a decline of 96.17% from the peak. This fundraising mechanism allows companies to sell shares gradually on the open market — but it also poses a genuine risk of dilution for existing shareholders. The sheer scale of the offering is what’s alarming traders: the filing covers an unusually large amount compared to the company’s roughly $1.07 million market value, raising dilution risks as the company can sell shares at prevailing prices with no minimums.PAVS Technical Analysis: Key Levels To WatchThe bigger-picture trend remains decisively bearish: PAVS is trading 43.1% below its 20-day SMA ($1.07) and 55.1% below its 50-day SMA ($1.36), keeping rallies "under" key trend gauges. It's also 92.4% below the 100-day SMA ($7.97) and 99.8% below the 200-day SMA ($325.00), which lines up with the stock's -99.94% slide over the last 12 months.Crossover structure is still a headwind, with the 20-day SMA below the 50-day SMA (bearish) and a longer-term death cross in place since June 2025 (50-day SMA below the 200-day SMA). That's the kind of alignment that tends to keep sellers active into bounces until price can reclaim at least the short moving averages.